Kathy Connell
Fortune : 14 340 $ au 31/08/2026
Fortune : 14 340 $ au 31/08/2026
Kathy Connell is the founder of Medicines Australia.
Current jobs include Non-Executive Director at Avecho Biotechnology Ltd. starting in 2024, Independent Non-Executive Director at Ceryvyn Therapeutics Ltd. starting in 2024, and Non-Executive Director at Proto Axiom Pty Ltd.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2026 | 2 000 000 ( 0,15% ) | 14 340 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AVECHO BIOTECHNOLOGY LIMITED | Directeur/Membre du Conseil | 26/04/2024 |
| CERYVYN THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 15/11/2024 |
Proto Axiom Pty Ltd.
Proto Axiom Pty Ltd. BiotechnologyHealth Technology Engages in drug development and medical equipment | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Avecho Biotechnology Ltd.
Avecho Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical and nutraceutical products | Health Technology |
Opthea Ltd.
Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Health Technology |
Proto Axiom Pty Ltd.
Proto Axiom Pty Ltd. BiotechnologyHealth Technology Engages in drug development and medical equipment | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national